ENVERIC BIOSCIENCES, INC. Entity Listing, Par Value Per Share
ENVERIC BIOSCIENCES, INC. (ENVB) reported Entity Listing, Par Value Per Share of $0.01 per share for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Cover Page
dei:EntityListingParValuePerShare · last filed 2026-08-14
- ENVERIC BIOSCIENCES, INC. entity listing, par value per share for the quarter ending 2026-03-31 was $0.01.
- ENVERIC BIOSCIENCES, INC. entity listing, par value per share for fiscal 2025 was $0.01, a 0.00% change from fiscal 2024.
- ENVERIC BIOSCIENCES, INC. entity listing, par value per share for fiscal 2024 was $0.01.
| Period end | Entity Listing, Par Value Per Share 3 month | Entity Listing, Par Value Per Share 6 month | Entity Listing, Par Value Per Share 9 month | Entity Listing, Par Value Per Share 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.01 10-Q · filed 2026-08-14 | |||
| 2026-03-31 | $0.01 10-Q · filed 2026-05-15 | |||
| 2025-12-31 | $0.01 10-K · filed 2026-03-27 | |||
| 2025-09-30 | $0.01 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | $0.01 10-Q · filed 2025-08-14 | |||
| 2024-12-31 | $0.01 10-K · filed 2025-03-28 | |||
| 2024-09-30 | $0.01 10-Q · filed 2024-11-14 | |||
| 2024-06-30 | $0.01 10-Q · filed 2024-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |